Patient P-01727
Synthetic patientNBL-101 · Day 107 · 25–34 · F · baseline S03Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
6%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S03
- Day 12 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 12.
Primary contributors, last 14 days
- GI instability-6
- Inflammatory activity-4
- Nutritional resilience-4
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion8.2/100
worsening · +10.8 vs previous 14 d
Toxicity
Blood14.8/100
worsening · +6.4 vs previous 14 d
Sleep quality
Wearable65.8/100
worsening · -3.3 vs previous 14 d
Energy level
Daily log6.9/10
worsening · -0.7 vs previous 14 d
Stress level
Daily log4.5/10
worsening · +0.7 vs previous 14 d
Steps
Wearable8,147
worsening · -921 vs previous 14 d
Adherence
Companion92.9 %
improving · +6.8 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 82 from the failing basin, 27 from restoration.
Good elements to keep
- Daily walks resumedperturbation · steering +3.3
Main detractors to watch
- Low butyrate capacityhidden · steering -17.5
- Dietary fat loadperturbation · steering -11.2
- Alcoholperturbation · steering -8.3
- Poor-sleep weekperturbation · steering -3
- Dietary fat loaddetractor · GI +6.7 next day
- Alcoholdetractor · GI +5.7 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Dietary fat load+6.7detractor · 95%
- Alcohol+5.7detractor · 95%
- Simple carbohydrates+1.5no signal · 27%
- Spicy / capsaicin+0.9no signal · 15%
- Insoluble fibre+0.5no signal · 15%
- Histamine load+0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓60
- MicrobiomeButyrate capacity 32/100
- MicrobiomeF. prausnitzii depleted
- Drug metabolism and exposure ↑35
- DNADPYD *2A → slower clearance
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
- Inflammatory signalling ↓15
- WearableHRV 38 ms, trending down
DNA
Fictional pharmacogenomic panel
- DPYD *2A heterozygousSlower drug clearance
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3 · butyrate capacity 32/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 37 ms
- Sleep
- 7.2 h
- Steps
- 7,694
- Resting HR
- 57 bpm
Daily log: GI score 8, nutritional resilience 71, adherence 93.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-01541 | 35% | S09 | AD-05 | no change | 43 |
| P-01679 | 35% | S12 | AD-05 | no change | 39 |
| P-01377 | 33% | S11 | AD-05 | no change | 42 |
| P-01483 | 33% | S14 | AD-05 | no change | 35 |
| P-01804 | 33% | S19 | AD-05 | improved | 61 |
| P-01773 | 30% | S05 | AD-05 | improved | 27 |
| P-01848 | 28% | S05 | AD-05 | no change | 23 |
| P-01350 | 34% | S19 | BR-03 | no change | 34 |
| P-01313 | 33% | S01 | BR-03 | improved | 32 |
| P-01468 | 32% | S06 | BR-03 | no change | 41 |
| P-01450 | 31% | S09 | BR-03 | no change | 36 |
| P-01689 | 30% | S13 | BR-03 | no change | 50 |